A patient being considered for targeted therapy should have which of the following performed?
Show answer and explanation
Correct answer: Biomarker/mutation testing of the tumour
Before starting targeted therapy, tumour tissue is often tested to detect whether a molecular target is present (eg. EGFR mutation, ALK rearrangement) to ensure the therapy is appropriate.
Practice all 20 Immunotherapy and Targeted Therapy questions
Keep practicing
More Immunotherapy and Targeted Therapy questions
- A nurse monitors a patient on immunotherapy for signs of “cytokine release syndrome” (CRS). This adverse effect is most often associated wi…
- In immunotherapy, the term “checkpoint” refers to:
- One major difference between targeted therapy and traditional chemotherapy is:
- Targeted therapy may fail over time due to:
- Which of the following statements about immunotherapy is accurate?
- Which of the following best characterises a targeted therapy’s side-effect profile compared to chemotherapy?